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Abstract Autophosphorylation of p21-activated protein kinase
Q-PAK is stimulated at 10 WM sphingosine in vitro and is
maximal at 100 WM. Sites autophosphorylated on Q-PAK in
response to sphingosine are identical to those obtained with
Cdc42(GTP). Autophosphorylation is paralleled by stimulation
of Q-PAK activity as measured with peptide and protein
substrates. In 3T3-L1 cells, sphingosine stimulates the autophos-
phorylation and activity of Q-PAK associated with the mem-
brane-containing particulate fraction by 2.8-fold, but does not
stimulate the activity of the soluble enzyme. Thus, Q-PAK is
activatable via a Cdc42-independent mechanism, suggesting
sphingosine has a role in Q-PAK activation under conditions of
cell stress. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Sphingosine is a lipid produced in cellular membranes as a
result of sphingolipid catabolism in response to di¡erent sig-
nals such as insulin, PDGF, phorbol esters, tumor necrosis
factor-K, and Q-irradiation [1^3]. Sphingosine can stimulate
the proliferation of di¡erent cell types, but also has cytostatic
and apoptotic properties [3^7].
Q-PAK (also known as PAK2) is a ubiquitous member of
the family of p21-activated protein kinases (PAKs) [8^10].
Binding of Cdc42(GTPQS) stimulates the autophosphorylation
and activity of Q-PAK. Q-PAK, but not K-PAK or L-PAK, is
activated by caspase cleavage during apoptosis [11^13]. In
contrast to K-PAK, which is activated by growth factors
and insulin [14^16], Q-PAK has been shown to have cytostatic
activity [17,18] and is activated by stimuli leading to cytostasis
or apoptosis [11,12,18^20]. Hyperosmolarity, Q-radiation and
treatment with the DNA-damaging agent AraC result in acti-
vation of Q-PAK; in contrast, both K-PAK and Q-PAK are
activated in response to UV and cisplatin [19,20].
The protein kinase activity of Q-PAK is regulated by
changes in autophosphorylation [21^23]. Eight autophosphor-
ylation sites have been identi¢ed in Q-PAK, seven serines lo-
cated in the regulatory domain, and one threonine in the
catalytic domain [23]. Activation of the enzyme correlates
with autophosphorylation of two serines (Ser-141 and Ser-
165) in the regulatory region and threonine (Thr-402) in the
activation loop.
Recently, sphingosine has been shown to induce autophos-
phorylation and activation of K-PAK towards exogenous sub-
strates [24]. In the present study, Q-PAK is shown to be auto-
phosphorylated and activated in response to sphingosine. In
3T3-L1 cells, sphingosine stimulation of Q-PAK activity oc-
curs in the membrane-containing particulate fraction and is
accompanied by increased phosphorylation of Q-PAK.
2. Materials and methods
2.1. Materials
Histone 4 was from Boehringer Mannheim; sphingosine from bo-
vine brain sphingomyelin (S6879), phosphatidylinositol, phosphatidyl-
serine, diacylglycerol and C6-ceramide were from Sigma. Antibody
speci¢c for Q-PAK (RR-1) was prepared in rat [17] or was obtained
from Santa Cruz Biotechnology, Inc. (N19). Peptide S3 (AKRESAA)
was synthesized and puri¢ed as described [25]. GTPQS was from
Boehringer Mannheim; [Q-32P]ATP was from Dupont NEN. GST-
Cdc42 was expressed in Escherichia coli and puri¢ed on glutathione-
Sepharose 4B [26].
2.2. Autophosphorylation of Q-PAK
The GST fusion protein of rabbit Q-PAK (Mr 88 kDa) was ex-
pressed in insect cells (TN5B-4) and puri¢ed on glutathione-Sepharose
4B. GST-Q-PAK has the same enzyme activity as Q-PAK [13,22]. Stock
solutions of sphingosine and C6-ceramide (10 mM) were prepared in
DMSO and diluted in 20 mM Tris^HCl, pH 7.4. GST-Q-PAK (0.10^
0.16 Wg) was incubated in 25 Wl containing 20 mM Tris^HCl, pH 7.4,
10 mM MgCl2, 30 mM 2-mercaptoethanol, and 0.2 mM [Q-32P]ATP
(1000^2000 cpm/pmol), with sphingosine or ceramide (0^400 WM), or
with Cdc42(GTPQS) [26]. Incubation was for 15 min at 30‡C. Auto-
phosphorylation of Q-PAK was analyzed on 12.5% polyacrylamide
gels, followed by autoradiography, and quanti¢ed by liquid scintilla-
tion counting.
2.3. Activity assays for Q-PAK
Following autophosphorylation of Q-PAK with sphingosine or C6-
ceramide, as described above, the synthetic peptide S3 (AKRESAA,
1 mM) and bovine serum albumin (0.4 mg/ml) were added to the reac-
tion in a ¢nal volume of 28 Wl. Incubation was for 15 min at 30‡C;
these were kinetically valid conditions and phosphorylation was linear
over time. The reactions were terminated with 5 Wl of 100 mM ATP at
0‡C and an aliquot (3^5 Wl) was subjected to thin-layer electrophoresis
on cellulose plates [25]. The 32P-labeled S3 peptide was identi¢ed by
autoradiography and quanti¢ed by liquid scintillation counting. As-
says with histone 4 or myelin basic protein (1 Wg) were carried out as
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described [25] and analyzed by SDS^PAGE on 15% polyacrylamide
gels.
2.4. Phosphopeptide mapping and phosphoamino acid analysis
Q-PAK (2.0 Wg) was autophosphorylated in the presence of 200 WM
sphingosine or Cdc42(GTPQS) and tryptic phosphopeptide maps were
obtained by two-dimensional peptide gel electrophoresis [23]. Phos-
phoamino acid analysis was carried out by thin-layer electrophoresis
[21].
2.5. Cell culture and preparation of cell extracts
Exponentially growing 3T3-L1 mouse preadipocytes (gift of Dr.
Charles S. Rubin, Albert Einstein College of Medicine) at 60% con-
£uency were treated for the indicated times with 15 WM sphingosine
(stock solution 10 mM in DMSO) or mock-treated with DMSO (Con-
trol). Cells were washed, harvested, and stored at 380‡C as indicated
[19]. Extracts were prepared in 0.5 ml of freshly prepared lysis bu¡er
containing phosphatase and protease inhibitors as described previ-
ously [19]. After 10 min on ice, the lysate was centrifuged at
16 000Ug for 10 min at 4‡C. The supernatant (soluble fraction) was
collected, and the pellet was solubilized by sonication on ice in 0.5 ml
of lysis bu¡er containing 1% NP40. After centrifugation at 16 000Ug
for 10 min at 4‡C, the supernatant was collected and designated as the
solubilized particulate fraction. Protein concentrations were deter-
mined using the Bradford assay [19].
2.6. Assay for Q-PAK activity in immunoprecipitates
Q-PAK was immunoprecipitated from the soluble and particulate
fractions (100 Wg of protein each) using 1 Wg of N19 antibody [19]
and assayed for 30 min with 2 Wg of histone 4 in a ¢nal volume of 30
Wl as described above. Radiolabeled histone 4 was quanti¢ed using a
PhosphorImager system. Western blot analysis of Q-PAK was as de-
scribed with horseradish peroxidase-linked secondary antibodies and
enhanced chemiluminescent detection [10,20].
3. Results
3.1. Stimulation of autophosphorylation and activity of Q-PAK
by sphingosine
Recombinant Q-PAK was autophosphorylated with [Q-32P]-
ATP using increasing concentrations of sphingosine. Auto-
phosphorylation was stimulated at concentrations as low as
10 WM and maximal stimulation was obtained at 100^400 WM
(Fig. 1). Increased autophosphorylation resulted in progres-
sively slower migrating forms of Q-PAK on SDS^PAGE. Only
a low level of autophosphorylation was observed with C6-cer-
amide, as compared to sphingosine. Other lipids, such as
phosphatidylserine, phosphatidylinositol or diacylglycerol,
did not stimulate autophosphorylation (data not shown). At
low concentrations of sphingosine (950 WM), up to 3 mol/mol
of phosphate was incorporated into Q-PAK. Maximal auto-
phosphorylation was 6^7 mol of phosphate incorporated/mol
of Q-PAK and was comparable to the level of autophosphor-
ylation obtained with Cdc42(GTPQS). These values correlate
with the eight autophosphorylation sites identi¢ed previously
for Q-PAK [23].
To examine the e¡ects of autophosphorylation on Q-PAK
activity, the samples were assayed with the peptide S3 (AK-
RESAA). At 950 WM sphingosine, there was a 3-fold stim-
ulation of Q-PAK activity (Fig. 2, upper panel). Q-PAK activ-
ity was stimulated 11-fold at concentrations of sphingosine
where maximal phosphorylation was observed (100^200
WM). Similar experiments with C6-ceramide showed little stim-
ulation of Q-PAK activity.
When phosphorylation of histone 4 and myelin basic pro-
tein was examined with sphingosine-activated Q-PAK (Fig. 2,
lower panel), the rate of phosphorylation was optimal at 100^
200 WM sphingosine. Phosphorylation of histone 4 was stimu-
lated 3^4-fold, and myelin basic protein 4^5-fold. Phosphor-
ylation obtained in the absence of sphingosine was due to
substrate-level activation of Q-PAK [26].
3.2. Phosphopeptide mapping of sphingosine-activated Q-PAK
To analyze the sites autophosphorylated in response to
sphingosine, tryptic digests of 32P-labeled Q-PAK were ana-
lyzed using two-dimensional peptide PAGE [23]; the tryptic
phosphopeptide pattern showed autophosphorylation at mul-
Fig. 1. Autophosphorylation and Q-PAK activity in response to
sphingosine and C6-ceramide. GST-Q-PAK (0.14 Wg) was autophos-
phorylated for 15 min with [Q-32P]ATP at the indicated concentra-
tions of sphingosine or C6-ceramide and analyzed by SDS^PAGE.
The autoradiogram is shown.
Fig. 2. Stimulation of Q-PAK activity by sphingosine. Upper panel:
GST-Q-PAK (0.14 Wg) was autophosphorylated at the indicated con-
centrations of sphingosine or C6-ceramide and assayed with peptide
S3. Lower panel: GST-Q-PAK (0.16 Wg) was autophosphorylated
and assayed with histone 4 (H4) or myelin basic protein (MBP).
Phosphorylation in the absence of sphingosine was set at 100% (1.9
pmol for H4, 1.0 pmol for MBP). Data are representative of three
experiments.
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tiple sites. Under these conditions, 6^7 mol of phosphate was
incorporated/mol of Q-PAK (Fig. 3, left panel). The phospho-
peptide pattern was similar, if not identical, to that observed
upon autophosphorylation with Cdc42(GTPQS) (Fig. 3, right
panel), and consistent with the autophosphorylation pattern
of active Q-PAK. As shown previously, in the absence of an
activator, Q-PAK was autophosphorylated, but not activated
[21]. Phosphoamino acid analysis of Q-PAK activated with
sphingosine or Cdc42(GTPQS) indicated that the majority
(V90%) of the phosphate was on serine, with less than 10%
on threonine. Without activators, only serine was observed
(data not shown).
3.3. Co-activation of Q-PAK by Cdc42 and sphingosine
To examine whether sphingosine activated Q-PAK through
a mechanism similar to that of Cdc42, the e¡ects of these
activators on Q-PAK activity were measured at suboptimal
conditions, where there is a linear relationship between the
activator concentration and degree of activation, and at opti-
mal concentrations to observe maximal activity. As shown in
Table 1, at low concentrations of Cdc42 (0.16 and 0.32 WM)
or sphingosine (10 WM), the level of activation of Q-PAK was
937% of the maximal activity observed at optimal concentra-
tions of Cdc42. When both activators were present at low
concentrations, activation was additive. At optimal concentra-
tions of Cdc42 (1.6 WM), where 6^7 mol of phosphate were
incorporated into Q-PAK, the level of activation attained with
Cdc42 was not augmented further by addition of suboptimal
or optimal concentrations of sphingosine. This would be ex-
pected if activation of Q-PAK in response to sphingosine and
Cdc42 was via the same mechanism, autophosphorylation.
3.4. Stimulation of Q-PAK activity in 3T3-L1 cells by
sphingosine
Exponentially growing 3T3-L1 cells were treated for up to
1 h with 15 WM sphingosine. This treatment induced cell round-
ing and inhibited cell growth if sustained for more than 12 h
(data not shown). Q-PAK was immunoprecipitated from the
soluble and solubilized particulate fractions with N19 anti-
body and Q-PAK activity was measured with histone 4. Fig.
4A (upper panel) shows no signi¢cant changes in Q-PAK ac-
tivity in the soluble fraction during 30 min of exposure to
sphingosine. After 1 h of exposure to sphingosine, the activity
of Q-PAK in the soluble fraction was reduced by 56% as com-
pared to the non-treated control cells. In contrast, sphingosine
induced a 2.8-fold increase in Q-PAK activity in the mem-
brane-containing particulate fraction at 15 min (Fig. 4A, low-
er panel). The e¡ects of sphingosine could be detected at
5 min, and Q-PAK activity was maximal at 15 min of treatment.
After 1 h, Q-PAK activity was reduced to the level of the
control. Similar results were obtained with an in-gel kinase
assay of Q-PAK using histone as substrate (data not shown).
As shown by Western blotting with N19 antibody, there
was little change in protein in the soluble fraction, while the
level of Q-PAK protein was signi¢cantly increased in the par-
ticulate fraction at 15^30 min following addition of sphingo-
sine to the cells (Fig. 4B). A second anti-Q-PAK antibody
Fig. 3. Comparison of tryptic phosphopeptides of Q-PAK activated
by sphingosine or Cdc42(GTPQS). Q-PAK (0.14 Wg) was autophos-
phorylated with [Q-32P]ATP in the presence of 100 WM sphingosine
or 1.6 WM Cdc42(GTPQS) and subjected to tryptic digestion. The
phosphopeptides were analyzed as described in Section 2. Left pan-
el: autoradiogram of Q-PAK activated by sphingosine. Right panel:
Q-PAK activated by Cdc42(GTPQS) (from Gatti et al. [23]).
Fig. 4. Sphingosine-induced phosphorylation and activation of Q-
PAK in 3T3-L1 cells. 3T3-L1 cells were treated for the indicated
times with 15 WM sphingosine in DMSO or with DMSO alone
(control). A: Q-PAK activity in the soluble and particulate fraction
was assayed with histone 4 following immunoprecipitation with N19
antibody. The mean þ S.E.M. of three separate experiments is
shown. The activity of the control cells was set as 100% for each
fraction. B: Q-PAK protein was determined by Western blotting
with N19, using equivalent amounts of soluble (30 Wg) or particu-
late protein (110 Wg). C: Immunoreactivity of Q-PAK with RR-1
antibody.
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(RR-1) recognizes the regulatory domain of Q-PAK and reacts
preferentially with highly autophosphorylated forms of acti-
vated Q-PAK [20]. In the absence of sphingosine, little if any
reactivity of RR-1 with Q-PAK was observed. Within 5 min
following addition of 15 WM sphingosine, signi¢cant immuno-
reactivity was observed with the RR-1 antibody and Q-PAK in
the particulate fraction (Fig. 4C). The immunoreactivity was
optimal between 15 and 30 min, indicating autophosphoryla-
tion of Q-PAK, and coincided with the stimulation of Q-PAK
activity (Fig. 4A). Little if any reactivity with RR-1 was ob-
served with Q-PAK in the soluble fraction before or after
sphingosine treatment. Taken together, the data indicate
that sphingosine stimulated the phosphorylation and activa-
tion of Q-PAK in the membrane-containing particulate frac-
tion of 3T3-L1 cells, but not in the soluble fraction.
4. Discussion
Q-PAK has been shown to be activated by binding of the
small GTPase protein Cdc42(GTP) and by cleavage with cas-
pase 3 (CPP32) [22^24]. Here we show that sphingosine in-
duces autophosphorylation and activation of Q-PAK both in
vitro and in vivo. Autophosphorylation of Q-PAK in vitro is
stimulated at concentrations of sphingosine as low as 10 WM
and is optimally activated at 100^400 WM, with a concomitant
stimulation of protein kinase activity, as assayed with peptide
S3 and two protein substrates.
The tryptic phosphopeptide map of Q-PAK autophosphory-
lated in response to sphingosine is identical to that obtained
with Q-PAK autophosphorylated in response to Cdc42-
(GTPQS) and coincides with the activation of Q-PAK. Acti-
vation in response to sphingosine includes autophosphoryla-
tion at Ser-141, Ser-165 and Thr-402, which are autophos-
phorylated only when Q-PAK is activated by Cdc42 [23]. This
supports a mechanism of activation of Q-PAK in which sphin-
gosine acts by stimulating autophosphorylation. This could
occur through disruption of the autoinhibitory interaction be-
tween the regulatory and the catalytic domains of Q-PAK, in a
manner similar to that described with K-PAK activated by
Cdc42 [9,27,28]. Data showing that the e¡ects of sphingosine
and Cdc42 on Q-PAK activity are additive at suboptimal con-
centrations, and saturable at high concentrations, support fur-
ther the idea that the lipid and Cdc42 activate Q-PAK through
a similar mechanism, with either stimulus fully activating Q-
PAK at optimal concentrations.
Previously, recombinant K-PAK has been shown to be ac-
tivated both in vitro and in vivo by sphingosine [24]. K-PAK
is activated when associated with membranes [24], and some
of the biological e¡ects of K-PAK activation can be mimicked
by arti¢cial targeting of the protein kinase to the plasma
membrane [29].
In the present study, we show that sphingosine has a direct
e¡ect on Q-PAK in vivo, stimulating the translocation and
activity of Q-PAK to the particulate fraction of 3T3-L1 cells.
This increased activity is concomitant with enhanced phos-
phorylation of Q-PAK in this fraction, as shown by Western
blotting with an antibody which reacts preferentially with ac-
tive autophosphorylated Q-PAK [20]. The e¡ects observed in
vivo thus support those observed in vitro, i.e. activation of Q-
PAK by sphingosine requires autophosphorylation. Thus, ac-
tivation of PAK by sphingosine in the membrane may be a
general mechanism of regulation of the activity of this family
of protein kinases in response to speci¢c stimuli.
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